Enquirer Consulting Group

Reachable Buyer Map

Prepared for Ajaykumar Bhatt · Medsource Ozone Biomedicals · August 2026
Diagnostics in India is not one market, it is five buying layers with almost nothing in common. Who signs, how fast they move, and whether they can be found at all changes completely between them. This is a read of those layers, the seats that sign inside each, and roughly how many sites sit there. It describes the market rather than your business, and there is nothing to buy at the end of it.
Standalone pathology and collection centers
The largest group on this page by a wide margin and the most fragmented. Single-site, owner-run, and buying on a short cycle, which makes the decision fast and the reach problem enormous. No field team covers a market this shape on foot.
Who signs: the owner pathologist, the lab manager, the purchase in-charge.
80,000 to 90,000
standalone labs and collection centers across India; the large majority are single-site
Labs inside small and mid-size private hospitals
A different buying motion from the standalone layer even though the equipment list is similar. Purchase runs through a materials function rather than the person using the instrument, so the technical case has to survive a handover to someone who is not a pathologist.
Who signs: hospital purchase head, materials manager, head of laboratory medicine, medical superintendent.
24,000 to 28,000
labs operating inside small and medium private hospitals, out of a private hospital universe usually put at 40,000 to 45,000
Accredited laboratories
Small as a share of the total and disproportionately important, because accredited sites carry documented method requirements and replace on a defined schedule. This is the layer that can actually be listed, named and worked account by account.
Who signs: quality manager, laboratory director, and at networks the corporate technical head.
2,000 to 2,500
medical labs holding accreditation to the international standard; accreditation attaches to a site and not to a brand, so a network with hundreds of collection points may hold it at only a handful of them
Organized networks and corporate hospital groups
Tiny by count, outsized by value, and the only segment where one relationship reaches dozens of sites at once. Instrument placement is decided centrally here and the conversation is commercial as much as technical.
Who signs: national procurement head, corporate technical lead, category manager, finance lead on multi-year placements.
150 to 250
multi-site diagnostic brands and corporate hospital groups; the organized layer is roughly a sixth of market revenue
Government, teaching and academic buyers
Bought on a calendar rather than in a conversation, through tender cells and purchase committees. Slow to enter and durable once entered, and the new-college pipeline creates a steady stream of first-time equipping decisions rather than replacements.
Who signs: head of pathology or microbiology, purchase committee chair, state procurement officers, dean or principal.
800 to 830
medical colleges, roughly 45 percent of them government, plus about 750 to 800 district hospitals and the state tender cells above them
The export distributor layer
Your widest market and the one no register describes. Importers, national distributors and tender agents in each country are identified one at a time, by name, from trade bodies, regulatory listings and the local market itself. Stated plainly, because it changes how the layer has to be worked.
Who signs: the distributor principal, the country product manager, the regulatory and registration lead.
No public register
importers and distributors are not enumerated anywhere public; the difficulty is exactly why this layer stays underworked by everyone

Where the openings are

1
A distributor reaches the accounts a distributor already carries. That is not a criticism of the channel, it is the arithmetic of it. Between the standalone layer and the hospital labs there are well over 100,000 buying sites in India alone. Any partner network covers the fraction it inherited and is silent about the rest, and the rest is not unqualified, it is unaware.
2
The accredited layer is roughly two percent of labs and it is the countable one. Everything else in Indian diagnostics has to be found. Accredited sites are published, addressable and already committed to documented methods, so they are the natural first named-account list. The trap is treating a network as one account when the accreditation, and often the purchase, sits at the individual site.
3
In the private layer the buyer wears two hats. The owner pathologist is the clinician and the purchaser in the same person, which shortens the cycle if you reach them and stalls it completely if you reach the front desk. A channel built on named roles gets to that seat. A channel built on territory gets to the building.
4
Export is a naming problem, not a volume problem. Reaching more than 45 countries through partners means the ceiling in each one is the partner, and the companies that could be a second partner, or a better one, are not on any list that can be bought. They have to be identified. That is mechanical work done at scale, and it is the piece a field team never has time for.
Built from public market data, counts banded deliberately. India lab and hospital totals come from published sector and accreditation sources rather than one register, and the widely quoted private hospital and total lab figures trace back to older baselines that get recycled, so they indicate scale rather than an exact count. Hospital definitions sweep in very small nursing homes, which inflates totals if the target is a fifty-bed facility or larger. The export distributor layer is not covered by any public register and is described rather than counted.
ENQUIRER CONSULTING GROUP
enquirerconsulting.com